Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ampyrone is a direct agonist of human tyrosinase and a potential therapeutic for hypopigmentation disorders.

JCI insight·2026
Same author

Combined inhibition of CDK4/6 and PI3K pathways exhibit highly synergistic activity and translational potential in Ewing sarcoma.

Translational oncology·2026
Same author

Hotter, faster, sicker? Warming shifts the cost of infection from individuals to populations.

The Journal of animal ecology·2026
Same author

Treatment deintensification in average-risk medulloblastoma: less is more?

Neuro-oncology·2026
Same author

Thermotactic Decision-Making in Aquatic Invertebrates: High-Resolution Behavioral Analysis of Ecotoxicological Effects.

Environmental science & technology·2026
Same author

Feasibility and utility of a tablet-based digital neurocognitive assessment following radiosurgery for brain metastases.

Scientific reports·2026
Same journal

RETRACTED: Sabir et al. DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges. <i>Cancers</i> 2021, <i>13</i>, 3396.

Cancers·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
See all related articles

Related Experiment Video

Updated: May 13, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

17.7K

Hypofractionated Radiotherapy for Soft Tissue Sarcomas.

Mehmet Murat Zerey1, Amna Gul1, Noah S Kalman1

  • 1Department of Radiation Oncology, Miami Cancer Institute, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33176, USA.

Cancers
|April 14, 2025
PubMed
Summary
This summary is machine-generated.

Hypofractionated radiotherapy shows comparable outcomes for soft tissue sarcomas (STS), offering shorter treatment times and reduced costs. This approach may improve patient compliance and streamline treatment pathways.

Keywords:
IMPTSABRSBRTSTShypofractionationproton therapyradiation therapyresectablestereotactic ablative radiation therapystereotactic body radiation therapytoxicities

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.1K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.2K

Related Experiment Videos

Last Updated: May 13, 2025

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

17.7K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.1K
Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.2K

Area of Science:

  • Oncology
  • Radiation Oncology

Background:

  • Soft tissue sarcomas (STS) management often involves standard fractionation radiotherapy.
  • Hypofractionated radiotherapy presents an alternative with potential benefits.

Purpose of the Study:

  • To review current evidence on hypofractionated radiotherapy for STS.
  • To provide an overview of its application in STS treatment.

Main Methods:

  • Comprehensive literature review.
  • Synthesis of existing evidence on hypofractionated radiotherapy in STS.

Main Results:

  • Hypofractionated radiotherapy may achieve similar local control as standard fractionation.
  • Comparable toxicity outcomes are suggested with shorter radiotherapy courses.
  • Reduced treatment time and potential for decreased healthcare costs.

Conclusions:

  • Hypofractionated radiotherapy is a viable option for STS management.
  • Shorter regimens can improve patient compliance and reduce treatment delays.
  • Further integration of hypofractionated radiotherapy in STS treatment protocols is supported.